
Mironid
- Mironid just raised $46M (Series B) on Aug 1
Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
About
Mironid is a biopharmaceutical company focused on developing first-in-class LoAc small molecule drug candidates that directly target the central signaling mechanism driving Autosomal Dominant Polycystic Kidney Disease (ADPKD). Their lead candidate, MR-L45, aims to reduce cyst formation and growth by activating long-form PDE4 enzymes, increasing the breakdown of cAMP, and offering a differentiated treatment option for patients with limited alternatives.
Show 6 more similar companies
Similar companies
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Rare Diseases
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Biotechnology, Genomics
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
Shares Biotechnology, Healthcare
Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Shares Biotechnology, Drug Discovery
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to Mironid?
People comparing tools land here. Get listed beside these.
Copy Mironid's SEO strategy
How often they publish, which searches their posts chase and their newest posts. Then outrank them.
All funding rounds
Key facts
- Website
- mironid.com
- Headquarters
- Glasgow, United Kingdom
- Founded
- 2015
- Founders
- Nigel Pyne, Miles Houslay
- Employees
- 16
- Total funding
- $46M (Series B)
- Business model
- B2B
Funding rounds
- $46M1 Aug 2026
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Aug 2026 | Series B | $46M | Scottish National Investment Bank |
Benchmarking
See how your site ranks against 16,849 startups
Mironid sits in the 19th percentile for Domain Rating. Check where yours lands, free.
Mironid has a Domain Rating of 12, the 19th percentile of 16,849 startups we track.
Measured, not editorial
Ahrefs DR
Bottom 25%
Check yoursEffective DR
Below median
Check yoursAgent Readiness
Bottom 25%
Scan yoursSite Speed
Above median
PageSpeedData Trust
Below median
Security
Click to scan
Agent Readiness
Can AI agents use your site?
Mironid scores 21. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when Mironid changes
Used Mironid? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
Frequently asked
Is Mironid growing?
Yes, fast. Our data shows it raised $46M in a Series B in August 2026.
Who owns Mironid?
Mironid is privately held, owned by its founders and investors. Investors on record include Scottish National Investment Bank, Roche Venture Fund, Epidarex Capital and Sofinnova Partners. Exact stakes are not public.
Are there companies like Mironid?
Yes. We list 6 companies like Mironid, including Moderna, Epicrispr Biotechnologies and Pixelgen Technologies.
What is Mironid's Effective Domain Rating?
StartupHub's Effective Domain Rating for Mironid is 62 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is underrated against its Ahrefs Domain Rating of 12, meaning it surfaces in search and AI results more than its claimed authority alone would suggest.
Is Mironid trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Mironid is 59 out of 100, a use-caution rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Mironid raised?
Mironid has raised a total of $46M in funding. The most recent round on record is Series B.
How many employees does Mironid have?
Mironid has approximately 16 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Mironid:
Company details: from public sources. Funding: 1 round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch Mironid and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini

